id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2010-D-0590-0001,FDA,FDA-2010-D-0590,"Guidance for Industry and Food and Drug Administration Staff; Availability, etc.: Blood Lancet Labeling",Notice,NAD-Notice of Availability of Data,2010-11-29T05:00:00Z,2010,11,2010-11-29T05:00:00Z,,2010-11-30T15:02:35Z,2010-29795,0,0,0900006480ba7c33
FDA-2010-D-0590-0002,FDA,FDA-2010-D-0590,Guidance for Industry and Food and Drug Administration Staff; Blood Lancet Labeling,Other,Guidance,2010-11-28T05:00:00Z,2010,11,2010-11-28T05:00:00Z,,2024-11-07T22:28:27Z,,1,0,0900006480ba84d1